Dianthus Therapeutics, Inc.

✨ #TalentTuesday ✨ At Dianthus, passion for groundbreaking scientific innovation fuels our work every day. We are honored to continue to build our team of highly driven leaders who will push the boundaries of complement therapeutics. Welcome to the team, Johan Jansson! #GrowWithUs #biotech #newhire

Catch our CEO, Marino Garcia, at Guggenheim Securities Global Healthcare Conference today! Listen to the presentation here: https://lnkd.in/gmNwdBQt #biotech #innovation #biotechnology 

Today, we reported our Q3 2024 financial results and announced our plan to initiate a single, two-part, pivotal Phase 3 trial of DNTH103 in CIDP by YE’24. Like gMG and MMN, CIDP has significant unmet needs where a best-in-class, potent classical pathway inhibitor can potentially make a meaningful difference in the lives of patients. Read more, including about our forward-thinking statements: https://lnkd.in/g8KQnYe3 #biotech #innovation #biotechnology

We’re excited to be at the following conferences in November and December. Marino Garcia will present at: • Guggenheim Securities Global Healthcare Conference • Jefferies London Healthcare Conference • Evercore ISI HealthCONx Conference #biotech #innovation #biotechnology

🚨 Hot Job Alert! 🚨   We are #hiring!   Our Senior / Executive Director, Medical Affairs - Regional Head position is a #remote role, which will lead and oversee Dianthus' medical affairs strategy and activities across the EU Region, including EMEA. If you’re based in the EU or UK and are passionate about the future of complement therapeutics and helping patients, we want to meet you! Learn more: https://lnkd.in/gPV7ppvN   #hiring #GrowWithUs #biotech #biotechnology

✨ #TalentTuesday ✨ The heart of our mission has stayed the same since day one: We strive to leave a positive impact on the lives of patients. We’re honored to continue building our team of innovators and passionate people, like Lindsay Hyde #GrowWithUs #biotech #newhire

✨ #TalentTuesday ✨ As our team continues to #GrowTogether, we are excited to announce we added 10 new team members this quarter who exemplify our core culture and mission here at Dianthus. Hear why Uzma H. Siddiqui, MD, our new Senior Director, Clinical Development, is excited to join the Dianthus team: #GrowWithUs #biotech #newhire

That’s a wrap! It was an incredible week of connecting with colleagues, hearing directly from a member of the patient community, workshopping our 2025 goals, and celebrating our success at our All-Company Meeting. Thank you to everyone for engaging in our workshops and fostering cross functional teamwork!   A special shoutout to our amazing meeting planner Bonni Scepkowski for another wonderful meeting-- we couldn’t have done it without you! And thank you to our photographer (www.jessicamchale.com) for capturing great photos!

We were honored to have Julie Bell, a member of our Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Patient Advisory Board, share her journey of living with CIDP. CIDP is a neurological disorder that can cause progressive weakness and sensory function. Each patient's journey is unique and CIDP can be very difficult to diagnose and treat effectively. Julie is a special education teacher and author from San Antonio, TX, who has been living with CIDP for nearly 30 years. She is passionate about providing disease awareness and advocating for CIDP patients as a volunteer with The GBS|CIDP Foundation International. Julie also wrote and published 𝘉𝘳𝘦𝘦’𝘴 𝘑𝘶𝘴𝘵 𝘓𝘪𝘬𝘦 𝘔𝘦, a children’s book about living with neuromuscular disease.

We kicked off our 6th semiannual All-Company Meeting last night with a reception and fireside chat with our CEO, Marino Garcia and Board Chair, Alison Lawton. Thank you, Alison, for generously sharing your inspiring career journey and stories of patient connections with our team!